Aspire BioPharma, Inc. (ASBP)vsHesai Group Sponsored ADR (HSAI)
ASBP
Aspire BioPharma, Inc.
$8.88
+5.21%
CONSUMER CYCLICAL · Cap: $11.80M
HSAI
Hesai Group Sponsored ADR
$13.83
+3.60%
CONSUMER CYCLICAL · Cap: $15.61B
Smart Verdict
WallStSmart Research — data-driven comparison
Hesai Group Sponsored ADR generates 3417128% more annual revenue ($3.34B vs $97,660). HSAI leads profitability with a 14.9% profit margin vs 0.0%. HSAI earns a higher WallStSmart Score of 62/100 (C+).
ASBP
Avoid22
out of 100
Grade: F
HSAI
Buy62
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 21.9% year-over-year
Earnings expanding 25.0% YoY
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Moderate valuation
ROE of 5.6% — below average capital efficiency
Operating margin of 0.3%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ASBP
The strongest argument for ASBP centers on Price/Book.
Bull Case : HSAI
The strongest argument for HSAI centers on Debt/Equity, PEG Ratio, Price/Book. Revenue growth of 21.9% demonstrates continued momentum. PEG of 0.52 suggests the stock is reasonably priced for its growth.
Bear Case : ASBP
The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.
Bear Case : HSAI
The primary concerns for HSAI are P/E Ratio, Return on Equity, Operating Margin.
Key Dynamics to Monitor
ASBP profiles as a value stock while HSAI is a growth play — different risk/reward profiles.
HSAI carries more volatility with a beta of 1.37 — expect wider price swings.
HSAI is growing revenue faster at 21.9% — sustainability is the question.
Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HSAI scores higher overall (62/100 vs 22/100) and 21.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aspire BioPharma, Inc.
CONSUMER CYCLICAL · AUTO PARTS · USA
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.
Visit Website →Hesai Group Sponsored ADR
CONSUMER CYCLICAL · AUTO PARTS · China
Hesai Group, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR). The company is headquartered in Shanghai, China.
Compare with Other AUTO PARTS Stocks
Want to dig deeper into these stocks?